The application of recombinant human granulocyte colony-stimulating factor (filgrastim) seems to be a safe, well tolerated and potentially effective therapy for active Crohn's disease. We report the case of an adolescent boy with Crohn's disease and intra-abdominal abscess associated who had a significant response to treatment with recombinant human granulocyte colony-stimulating factor after all standard treatments had failed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1157/13100593 | DOI Listing |
Publication Analysis
Top Keywords
crohn's disease
12
disease intra-abdominal
8
recombinant human
8
human granulocyte
8
granulocyte colony-stimulating
8
colony-stimulating factor
8
[filgrastim refractory
4
refractory crohn's
4
intra-abdominal abscess]
4
abscess] application
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!